Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $3.5100 (0.14%) ($3.5100 - $3.5100) on Mon. Mar. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.01% (three month average) | RSI | 26 | Latest Price | $3.5100(0.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -1.4% a day on average for past five trading days. | Weekly Trend | AUTL declines -9.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(65%) IBB(61%) IBUY(53%) IWO(51%) XRT(49%) | Factors Impacting AUTL price | AUTL will decline at least -2.005% in a week (0% probabilities). VIXM(-49%) SHY(-30%) TLT(-28%) VXX(-27%) TIP(-26%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.005% (StdDev 4.01%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-12.74(-462.96%) | Resistance Level | $4.09 | 5 Day Moving Average | $3.65(-3.84%) | 10 Day Moving Average | $3.76(-6.65%) | 20 Day Moving Average | $4.09(-14.18%) | To recent high | -48.9% | To recent low | 0.1% | Market Cap | $183m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |